Zuclopenthixol Short-Acting Intramuscular Injection 50 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Short-acting Intramuscular Injection
Available Strengths: 50 mg/mL
Reference Brands: Clopixol-Acuphase®
Category: Antipsychotropic Drugs
Zuclopenthixol short-acting IM injection is a typical antipsychotic that works by blocking dopamine D2 receptors, helping to rapidly reduce symptoms of acute psychosis and agitation. It is primarily used in emergency settings to calm aggressive or severely disturbed patients with schizophrenia or related psychotic disorders, offering quick symptom control
Product Description: Zuclopenthixol short-acting intramuscular injection, commonly used in acute psychosis and agitation, is not currently approved by the FDA in the United States but is available in several EU markets under Clopixol-Acuphase. In the EU, it follows EMA regulatory standards for parenteral antipsychotics, requiring GMP compliance, stability data, and clinical justification for emergency psychiatric use. U.S. registration would require a detailed regulatory strategy, including an IND or 505(b)(2) approach. To explore other dosage forms, strengths, and dossier-ready Zuclopenthixol IM injection products, visit Pharmatradz.com — your trusted global B2B platform for API and finished formulations.
Zuclopenthixol Short-Acting Intramuscular Injection — third party manufacturing & bulk supply
Zuclopenthixol Short-Acting Intramuscular Injection 50 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Zuclopenthixol Short-Acting Intramuscular Injection is supplied as Short-acting Intramuscular Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Zuclopenthixol Short-Acting Intramuscular Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Zuclopenthixol Short-Acting Intramuscula... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
